The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a recall of a batch of Crescent Pharma's ramipril 2.5mg capsules due to a packaging error that resulted in some boxes containing 10mg capsules. This medication is commonly prescribed for high blood pressure, heart failure, and kidney disease. The recall was initiated after a health professional discovered two blister strips of 10mg tablets inside a sealed box labeled as 2.5mg. Patients are advised to check their packaging for the batch number GR155023 and ensure that the strength on the carton matches the blister strips inside. If the packaging contains the incorrect dosage, patients should not take the medication and should contact their pharmacy. Symptoms of taking the higher dose may include dizziness, fainting, and altered kidney function, particularly in vulnerable individuals. The MHRA has recommended that affected patients report any side effects through the Yellow Card scheme and consult with healthcare professionals for further assessment.